The historical rank and industry rank for The Medicines Co's Price-to-Tangible-Book or its related term are showing as below:
MDCO's Price-to-Tangible-Book is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.36 * Ranked among companies with meaningful Price-to-Tangible-Book only.
The Medicines Co Price-to-Tangible-Book Historical Data
The historical data trend for The Medicines Co's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Medicines Co's Price-to-Tangible-Book
For the Drug Manufacturers - Specialty & Generic subindustry, The Medicines Co's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Medicines Co's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, The Medicines Co's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where The Medicines Co's Price-to-Tangible-Book falls into.
The Medicines Co Price-to-Tangible-Book Calculation
The Medicines Co's price-to-tangible-book ratio for today is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
The Medicines Co Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of The Medicines Co's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
The Medicines Co (The Medicines Co) Business Description
The Medicines Company is a pharmaceutical firm that provides products to the U.S. hospital market. The company's primary commercial product, Angiomax, is an anticoagulant drug used in conjunction with aspirin for patients undergoing angioplasty. Medicines recently commercialized a new drug, Cleviprex, which is designed to control blood pressure in intensive-care settings.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MDCO has been successfully added to your 